5 European Projects Found
Searched on 125080 European Projects
FINISHED
Combatting Bacterial Resistance in Europe - Carbapenem Resistance (COMBACTE-CARE)
Start date: Mar 1, 2015, End date: Feb 28, 2020,
Multi-drug resistant Gram-negative bacteria (MDR-GNB): the ultimate challenge!Antibiotic resistance is a global public health concern recently elevated to the top three threats identified by the WHO, and subject of numerous national and international government activities. Although focused strategies have beneficially influenced infection rates due to methicillin resistant Staphylococcus aureus (M ...
Read Project
23
Partners Participants
FINISHED
Pax8 as a marker of Ovarian cancer Originating in the Fallopian tube (PASCAL)
Start date: Dec 1, 2014, End date: Nov 30, 2018,
"Epithelial ovarian cancer is a disease with grim prognosis and high-grade serous carcinoma (HGSC) is its most common subtype. Recent literature suggests that HGSC arises in the fallopian tube (FT) epithelium, rather then in the ovary, and metastasizes to the ovary early on in the process of transformation. This hypothesis is based, among other findings, on common morphologic and immunophenotypic ...
Read Project
1
Partner Participant
FINISHED
Preserving old antibiotics for the future : assessment of clinical efficacy by a pharmacokinetic/pharmacodynamic approach to optimize effectiveness and reduce resistance for off-patent antibiotics (AIDA)
Start date: Dec 1, 2011, End date: Nov 30, 2017,
...ty. An effective dissemination strategy is essential to effectively communicate project results to the target groups therefore supporting the project goal of preserving and strengthening the public health benefits of the studied off-patent antibiotics. The dissemination of project results to professional groups and the public in general, communication to policymakers, and implementation of results ...
Read Project
19
Partners Participants
FINISHED
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk (ABIRISK)
Start date: Mar 1, 2012, End date: Feb 28, 2017,
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia and multiple sclerosis, caring for ~30,000 patients treated with biopharmaceuticals, with ~10,000 additional patients recru ...
Read Project
39
Partners Participants
FINISHED
Enigma – Histone Deacetylase protein complex controls cardiac hypertrophy (ENIGMA)
Start date: Jul 1, 2012, End date: Jun 30, 2016,
"A variety of cardiovascular disorders provoke the heart to enlarge through hypertrophic growth of cardiomyocytes, resulting in heart failure and sudden death. Based on in vivo and in vitro models of cardiac hypertrophy, it is apparent that histone-modifying enzymes act as key regulators of cardiac growth. Although their upstream regulation has been studied, the mechanism whereby class IIa Histone ...
Read Project
